Tillman Gerngross and Ram Sasisekharan
March 20, 2023 11:12 AM EDT
People

'No find­ing of re­search mis­con­duc­t': MIT ends 3.5-year re­view of biotech founder, pro­fes­sor Sasisekha­ran

Kyle LaHucik

Senior Reporter

The Mass­a­chu­setts In­sti­tute of Tech­nol­o­gy said it found no re­search mis­con­duct af­ter al­le­ga­tions were levied against bi­o­log­i­cal en­gi­neer­ing pro­fes­sor and re­peat biotech founder Ram Sasisekha­ran …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times